30th Aug 2006 10:00
Smith & Nephew Plc30 August 2006 FOR IMMEDIATE RELEASE Contact: Sidonie Myers Head of Communication Smith & Nephew Advanced Wound Management +44 (0) 1482 673246 [email protected] Smith & Nephew announces European launch of enhanced ALLEVYN+ Non-Adhesivedressings HULL, UK August 30 2006 - Smith & Nephew's (LSE: SN; NYSE:SNN) Advanced WoundManagement division, announced today that it is launching a new and enhancedversion of ALLEVYN Non-Adhesive. This is the second stage in the roll out of thenew enhanced ALLEVYN product range, following the successful launch of newALLEVYN Adhesive and Sacrum earlier in the year. The new ALLEVYN Non-Adhesive dressings deliver the optimal moist woundenvironment for the promotion of faster healing, by combining new technologicaladvancements with the existing benefits of ALLEVYN. The dressings now have up tothree times more fluid handling capacity as a result of a more breathable topfilm and a faster rate of fluid uptake. This is combined with a unique designfeaturing sealed and shaped edges that provide protection against leakage. "Following on from the extremely successful launch of the new ALLEVYN Adhesiveproducts earlier in the year, this second launch further strengthens ALLEVYN'sposition as the leading global brand within the foam dressings market" said JoeWoody, President, Smith & Nephew Advanced Wound Management. "These enhancements mean that the ALLEVYN range ofproducts offer even more benefits to our customers and will continue to improvethe quality of life of their patients." ALLEVYN helps to facilitate healing by reducing the risk of maceration andmaintaining an optimal moist wound environment. ALLEVYN offers the clinician aclinically proven range of dressings that are cost effective both for theclinician and the buyer. "I have recently been using the new ALLEVYN Non-Adhesive dressings on mypatients in Niagara, Canada, and in my view these dressings provide superiorfluid handling, with an improvement in conformability, absorbency and wear time.This makes the dressings more comfortable for my patients and helps to preventmaceration to the surrounding skin. The fact that the dressings can be changedless frequently makes my patients' lives easier, thereby enhancing and improvingtheir quality of life." Theresa Hurd, Advanced Practice Nurse Specialist,Niagara, Canada. Smith & Nephew Advanced Wound Management, with headquarters in Hull, UK employsmore than 2,500 people around the world with approximately half based in theirmain manufacturing facility in Hull. The organisation also has a manufacturingcentre in the US in Largo, Florida. + Trademark of Smith & Nephew Notes for Editors About Smith & Nephew Smith & Nephew is a global medical technology business, specialising inOrthopaedic Reconstruction, Orthopaedic Trauma, Endoscopy and Advanced WoundManagement products. Smith & Nephew is a global leader in arthroscopy andadvanced wound management and is one of the leading global orthopaedicscompanies. Smith & Nephew is dedicated to helping improve people's lives. Thecompany prides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The company has more than 8,500employees and operates in 33 countries around the world and generated sales inexcess of $2.6 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within themeaning of the US Private Securities Litigation Reform Act of 1995. Inparticular, statements regarding expected revenue growth and trading marginsdiscussed under "Outlook" are forward-looking statements as are discussions ofour product pipeline. These statements, as well as the phrases "aim", "plan","intend", "anticipate", "well-placed", "believe", "estimate", "expect","target", "consider" and similar expressions, are generally intended to identifyforward-looking statements. Such forward-looking statements involve known andunknown risks, uncertainties and other important factors (including, but notlimited to, the outcome of litigation, claims and regulatory approvals) thatcould cause the actual results, performance or achievements of Smith & Nephew,or industry results, to differ materially from any future results, performanceor achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S.Securities and Exchange Commission under the U.S. Securities Exchange Act of1934, as amended, including Smith & Nephew's most recent annual report on Form20F, for a discussion of certain of these factors. All forward-looking statements in this press release are based on informationavailable to Smith & Nephew as of the date hereof. All written or oralforward-looking statements attributable to Smith & Nephew or any person actingon behalf of Smith & Nephew are expressly qualified in their entirety by theforegoing. Smith & Nephew does not undertake any obligation to update or reviseany forward-looking statement contained herein to reflect any change in Smith &Nephew's expectation with regard thereto or any change in events, conditions orcircumstances on which any such statement is based. *Unless otherwise specified as reported, all revenue increases throughout this document are underlying increases which adjust for the effects of currency translation. # # # This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew